Expertise in
4
conditions

Sadashivudu Gundeti

Hyderabad, TG, IN 
Expertise in
4
conditions
Hyderabad, TG, IN 

Overview

Sadashivudu Gundeti practices practicing medicine in Hyderabad, India.

Gundeti is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Febrile Neutropenia, Agranulocytosis, and Leukemia.

They are actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 2 clinical trials.

Locations

Hyderabad, TG, India
Other Locations
Hyderabad, AP, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

42 Total Publications

Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries.
Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries.
Journal: The New England journal of medicine
Published: March 25, 2026

Frequently Asked Questions about Sadashivudu Gundeti

Is Sadashivudu Gundeti a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Sadashivudu Gundeti is classified as an Advanced expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sadashivudu Gundeti participate in research or clinical trials?

Yes. Sadashivudu Gundeti has published 42 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Sadashivudu Gundeti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gundeti's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile